While 96–100% of ovarian adenocarcinomas are CK 7+/CK 20−, compared with only 11–63% of bladder cancers [4, 5], urothelial carcinomas display immunohistochemical GATA3 positivity whereas ovarian cells do not [6, 7]. This evidence concerns the gene GATA3 and urothelial carcinoma.